Clinical Trials Directory

Trials / Unknown

UnknownNCT01874600

Seizure Detection and Warning System for Epilepsy Patients

A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
239 (actual)
Sponsor
Brain Sentinel · Academic / Other
Sex
All
Age
13 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to alert caregivers that a seizure is occurring.

Conditions

Interventions

TypeNameDescription
DEVICEBrain Sentinel Seizure Detection Device and Warning SystemThe Brain Sentinel Seizure Detection Device and Warning System is designed to monitor Epilepsy patients and alerts caregivers that a GTC seizure is occurring

Timeline

Start date
2013-07-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2013-06-11
Last updated
2019-07-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01874600. Inclusion in this directory is not an endorsement.

Seizure Detection and Warning System for Epilepsy Patients (NCT01874600) · Clinical Trials Directory